James P Angiulo Foundation To Cure Brain Tumors Tucson, AZ - 85718

James P Angiulo Foundation To Cure Brain Tumors is categorized under Organizations in Tucson, AZ and active since 2009.

James P Angiulo Foundation To Cure Brain Tumors was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Organizations business, which does work in the BOTH market, and is classified as a Organizations, under code number 813410 by the NAICS.

If you are seeking more information, feel free to contact Nanette R Angiulo at the company’s single location by writing to 4280 East La Paloma Drive, Tucson, Arizona AZ 85718 or by phoning (520) 529-2075. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: James P Angiulo Foundation To Cure Brain Tumors
Contact Person: Nanette R Angiulo
Address: 4280 East La Paloma Drive, Tucson, Arizona 85718
Phone Number: (520) 529-2075
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Organizations
SIC Code: 8699
NAICS Code: 813410
Share This Business:

James P Angiulo Foundation To Cure Brain Tumors was started in 2009 to provide professional Organizations under the SIC code 8699 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Nanette R Angiulo for inquiries that concern James P Angiulo Foundation To Cure Brain Tumors by calling the company number (520) 529-2075, as your correspondence is most welcome. Additionally, the physical location of the single location of James P Angiulo Foundation To Cure Brain Tumors can be found at the coordinates 32.333981,-110.901222 as well as the street address 4280 East La Paloma Drive in Tucson, Arizona 85718.

For its online presence, you may visit James P Angiulo Foundation To Cure Brain Tumors’s website at and engage with its social media outlets through on Twitter and on Facebook.